Study Finds Medicaid Reimbursement for Radiation Therapy Varies Widely State-to-State
A new study found wide state-to-state variations in Medicaid reimbursements to physicians who treat patients with cancer with radiation therapies. These differences could compound existing disparities in access to health care in rural communities, which tend to have higher Medicaid coverage rates than metropolitan areas. The study was published by Agarwal et al in the International Journal of Radiation Oncology • Biology • Physics.
“Roughly 66 million low-income Americans are enrolled in Medicaid, and we know from previous studies [Parik-Patel et al in Medicine, Access to Care in Cancer 2016: Barriers and Challenges] that these patients face disproportionate difficulty and delays getting the care they need,” said Ankit Agarwal, MD, MBA, first author of the study and a radiation oncology resident physician at the University of North Carolina at Chapel Hill. “With cancer care, timely treatment matters, and states that undercompensate for radiation therapy likely undermine patients’ health outcomes.”
Findings
For the analysis, researchers examined 2017 Medicaid fee schedules from 48 states and the District of Columbia. Key findings included:
- Fivefold difference in reimbursement rates: The average reimbursement for standard-of-care radiation therapy to treat breast cancer ranged from a low of $2,945 in New Hampshire to a high of $15,218 in Delaware, with an overall average of $7,233 for an entire episode of care.
- Radiation oncology disproportionately affected: The variation in radiation therapy payments outpaces the differences seen with other Medicaid reimbursements. Analysis of the Kaiser Family Foundation Medicaid-to-Medicare fee index for general medical services found that reimbursement ratios ranged from a low of 0.38 in Rhode Island to a high of 1.26 in Alaska—a threefold difference. By comparison, the authors’ index of radiation oncology payments showed a fivefold difference.
The correlation coefficient of the Kaiser Family Foundation Medicaid-to-Medicare fee index to the calculated entire episode of care for each state was 0.55.
“Clinics that provide radiation therapy also have expensive fixed costs to purchase and maintain the equipment used for treatments. Inadequate and disproportionate Medicaid reimbursement rates—which already fall below comparable Medicare rates—can negatively impact the viability of facilities, especially in rural and private practice settings. Any reduction in the number of facilities in these areas can limit or remove patient access to these life-saving medical services,” explained Dr. Agarwal.
“Greater stability and fairness in Medicaid compensation would help stabilize access for Medicaid patients and make it more financially feasible for the physicians who care for them, especially in rural communities and those with fewer physicians overall. If left unaddressed, however, the disparity could aggravate the growing maldistribution of radiation oncologists in rural and urban communities—and place low-income patients in rural communities at even greater threat,” he concluded.
Disclosure: The study authors’ full disclosures can be found at redjournal.org.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
